BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38215108)

  • 1. The impact of preoperative interview and prospective nursing on perioperative psychological stress and postoperative complications in patients undergoing TACE intervention for hepatocellular carcinoma.
    Gao L; Chen W; Qin S; Yang X
    Medicine (Baltimore); 2024 Jan; 103(2):e35929. PubMed ID: 38215108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.
    Lv N; Kong Y; Mu L; Pan T; Xie Q; Zhao M
    Eur Radiol; 2016 Oct; 26(10):3492-9. PubMed ID: 26801163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of postoperative prophylactic transcatheter arterial chemoembolization (TACE) and transhepatic arterial infusion (TAI) after hepatectomy for primary liver cancer.
    Chen J; Zhang Y; Cai H; Yang Y; Fei Duan Y
    J BUON; 2018; 23(3):629-634. PubMed ID: 30003729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma.
    Luo YQ; Wang Y; Chen H; Wu MC
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):523-6. PubMed ID: 14607679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
    Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
    Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone.
    Hassanin TM; Fouad Y; Hassnine A; Eisawy M; Farag N; Abdel Ghany W
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1255-1261. PubMed ID: 33906320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.
    Xu JX; Qin SL; Wei HW; Chen YY; Peng YC; Qi LN
    Ann Med; 2023 Dec; 55(1):2199219. PubMed ID: 37070467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.
    Zhang YF; Guo RP; Zou RH; Shen JX; Wei W; Li SH; OuYang HY; Zhu HB; Xu L; Lao XM; Shi M
    Eur Radiol; 2016 Jul; 26(7):2078-88. PubMed ID: 26396105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
    Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
    J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical feasibility and safety of laparoscopic right hepatectomy for hepatocellular carcinoma following sequential TACE-PVE: a comparative study.
    Goumard C; Komatsu S; Brustia R; Fartoux L; Soubrane O; Scatton O
    Surg Endosc; 2017 May; 31(5):2340-2349. PubMed ID: 27655376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?
    Harada T; Matsuo K; Inoue T; Tamesue S; Inoue T; Nakamura H
    Ann Surg; 1996 Jul; 224(1):4-9. PubMed ID: 8678616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma.
    Guo JG; Zhao LP; Rao YF; Gao YP; Guo XJ; Zhou TY; Feng ZY; Sun JH; Lu XY
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):510-516. PubMed ID: 30135046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the comparison of postoperative liver injury caused by hepatic arterial perfusion chemotherapy combined with targeted immunotherapy with hepatic arterial chemoembolization combined with targeted immunotherapy for intermediate-and advanced-stage liver cancer].
    Li R; Li WL; Yuan GS; Pang HJ; Li Q; Hu XY; Guo YB; Chen JZ; Zang MY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1163-1168. PubMed ID: 38238949
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence.
    Sugo H; Futagawa S; Beppu T; Fukasawa M; Kojima K
    World J Surg; 2003 Dec; 27(12):1295-9. PubMed ID: 14574482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of preoperative transcatheter arterial chemoembolization on the perioperative outcome of patients with hepatocellular carcinoma].
    Rong W; Yu W; Wu F; Wu J; Wang L; Tian F; An S; Feng L; Liu F
    Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):671-5. PubMed ID: 26813431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T; Qi H; Shen L; Wu Y; Song Z; Cao F; Liu Y; Xie L; Chen S; Tang T; Li H; Zhang Y; Feng L; Zhang H; Chen J; Fan W
    Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
    [No Abstract]   [Full Text] [Related]  

  • 20. Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis.
    Sneiders D; Boteon APCS; Lerut J; Iesari S; Gilbo N; Blasi F; Larghi Laureiro Z; Orlacchio A; Tisone G; Lai Q; Pirenne J; Polak WG; Perera MTPR; Manzia TM; Hartog H
    Br J Surg; 2021 Nov; 108(11):1323-1331. PubMed ID: 34611694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.